Newborn Screening for Hemoglobinopathies

Melissa Frei-Jones

doi:10.1007/978-3-030-49980-8_21

Newborn Screening for Hemoglobinopathies

Melissa Frei-Jones

Research output: Chapter in Book/Report/Conference proceeding › Chapter

1 Scopus citations

Abstract

Inherited hemoglobin disorders including sickle cell disease (SCD) and the thalassemia syndromes represent a heterogeneous group of inherited blood disorders that have been shown to benefit from early detection and intervention. Newborn screening (NBS) programs are the primary method by which we detect children affected by hemoglobinopathy disorders.

Original language	English (US)
Title of host publication	Benign Hematologic Disorders in Children
Subtitle of host publication	A Clinical Guide
Publisher	Springer Science+Business Media
Pages	312-321
Number of pages	10
ISBN (Electronic)	9783030499808
ISBN (Print)	9783030499792
DOIs	https://doi.org/10.1007/978-3-030-49980-8_21
State	Published - Jan 1 2020
Externally published	Yes

ASJC Scopus subject areas

General Medicine

Access to Document

10.1007/978-3-030-49980-8_21

Cite this

@inbook{df008d8348e9493ab335cedec3a50c67,

title = "Newborn Screening for Hemoglobinopathies",

abstract = "Inherited hemoglobin disorders including sickle cell disease (SCD) and the thalassemia syndromes represent a heterogeneous group of inherited blood disorders that have been shown to benefit from early detection and intervention. Newborn screening (NBS) programs are the primary method by which we detect children affected by hemoglobinopathy disorders.",

author = "Melissa Frei-Jones",

note = "Publisher Copyright: {\textcopyright} Springer Nature Switzerland AG 2021.",

year = "2020",

month = jan,

day = "1",

doi = "10.1007/978-3-030-49980-8\_21",

language = "English (US)",

isbn = "9783030499792",

pages = "312--321",

booktitle = "Benign Hematologic Disorders in Children",

publisher = "Springer Science+Business Media",

}

TY - CHAP

T1 - Newborn Screening for Hemoglobinopathies

AU - Frei-Jones, Melissa

N1 - Publisher Copyright: © Springer Nature Switzerland AG 2021.

PY - 2020/1/1

Y1 - 2020/1/1

N2 - Inherited hemoglobin disorders including sickle cell disease (SCD) and the thalassemia syndromes represent a heterogeneous group of inherited blood disorders that have been shown to benefit from early detection and intervention. Newborn screening (NBS) programs are the primary method by which we detect children affected by hemoglobinopathy disorders.

AB - Inherited hemoglobin disorders including sickle cell disease (SCD) and the thalassemia syndromes represent a heterogeneous group of inherited blood disorders that have been shown to benefit from early detection and intervention. Newborn screening (NBS) programs are the primary method by which we detect children affected by hemoglobinopathy disorders.

UR - https://www.scopus.com/pages/publications/105009180594

UR - https://www.scopus.com/pages/publications/105009180594#tab=citedBy

U2 - 10.1007/978-3-030-49980-8_21

DO - 10.1007/978-3-030-49980-8_21

M3 - Chapter

AN - SCOPUS:105009180594

SN - 9783030499792

SP - 312

EP - 321

BT - Benign Hematologic Disorders in Children

PB - Springer Science+Business Media

ER -

Newborn Screening for Hemoglobinopathies

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this